Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455734) titled 'Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors' on March 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: BioNTech SE
Condition:
Advanced Solid Tumor Cancer
Intervention:
Drug: BNT3214
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 2026
Target Sample Size: 533
To know more, visit https://clinicaltrials.gov/study/NCT07455734
Published by HT Digital Content Servic...